FDA Drug recall D-0015-2026
Oxytocin 30 Units/500 mL in 0.9% Sodium Chloride for intravenous use, Rx only, IntegraDose Compounding Services LLC, 719 Kasota Ave Se, Min…
- FDA Drug
- Class I
- ongoing
- Published 2025-10-22
On 2025-10-22 the FDA classified a Class I recall of Oxytocin 30 Units/500 mL in 0.9% Sodium Chloride for intravenous use, Rx only, IntegraDose Compounding Services LLC, 719 Kasota Ave Se, Min… by Integradose Compounding Services, citing subpotent Drug: Testing revealed there was no oxytocin in the IV bag.
Read the official FDA Drug notice
| Agency | FDA Drug |
|---|---|
| Recall number | D-0015-2026 |
| Classification | Class I |
| Status | ongoing |
| Initiated | 2025-09-16 |
| Published | 2025-10-22 |
| Last updated | 2026-09-13 11:52 UTC |
| Company | Integradose Compounding Services |
| Distribution | US |
Product
Oxytocin 30 Units/500 mL in 0.9% Sodium Chloride for intravenous use, Rx only, IntegraDose Compounding Services LLC, 719 Kasota Ave Se, Minneapolis, MN 55414-2842 NDC 71139-0012-1
Reason
Subpotent Drug: Testing revealed there was no oxytocin in the IV bag.
Identifiers
| code_info | Lot #: 20250620OXY-1, Expiration date 10/18/2025 |
|---|
Status history
No status changes recorded since RecallRadar first saw this recall on 2026-09-13 11:52 UTC. Current status: ongoing.
Source
Official record: https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0015-2026%22
RecallRadar indexes public recall notices from the FDA, USDA FSIS, and CPSC. The official agency notice is the authoritative source. Always confirm details at the linked source before acting.